METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION
US Application 62/565,464
Filed on 2017-09-29
Filed on 2017-09-29
T CELL RECEPTORS RECOGNIZING MUTATED P53
US Application 62/565,383
Filed on 2017-09-29
Filed on 2017-09-29
TREATING OR PREVENTING ADVERSE LIVER CONDITIONS BY ADMINISTERING A PRIMARY BILE ACID
US Application 62/578,176
Filed on 2017-10-27
Filed on 2017-10-27
ANTI-CANCER ACTIVITY OF SCGB3A2 AND LPS
US Application 62/619,511
Filed on 2018-01-19
Filed on 2018-01-19
IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN
US Application 62/559,926
Filed on 2017-09-18
Filed on 2017-09-18
EXO-CLEAN METHOD FOR REMOVING PROTEINS AND UNBOUND LABELS FROM EXTRACELLULAR VESICLE PREPARATIONS
US Application 62/612,040
Filed on 2017-12-29
Filed on 2017-12-29
METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION
US Application 62/568,339
Filed on 2017-10-05
Filed on 2017-10-05
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
US Application 62/560,930
Filed on 2017-09-20
Filed on 2017-09-20
Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range
US Application 62/549,566
Filed on 2017-08-24
Filed on 2017-08-24
Ultrasound Sensitive Peptide Nanoparticles For Spatially Resolved Molecule Delivery
US Application 62/538,116
Filed on 2017-07-28
Filed on 2017-07-28